Stephen Worsley is VP of Business Development for Peregrine Pharmaceuticals and Avid Bioservices, bringing over 25 years’ experience in the biotechnology industry, with 16 of those in business development. Previously, he was chief business officer at Centrose Pharmaceuticals and held business development positions at Intrexon, Zosano Pharma, Raven Biotechnologies, Abgenix, Tripos Drug Discovery, and OHM Technologies. Stephen holds an MBA in finance from the University of Washington and a Bachelor of Science in international economics and finance from the University of Utah.